Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrate

被引：1
|
作者：
Brand, Toni M. [1 ]
Wheeler, Deric L. [1 ]
机构：
[1] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Ctr Comprehens Canc, Madison, WI 53201 USA
来源：
CANCER BIOLOGY & THERAPY | 2011年 / 11卷 / 03期
关键词：
breast cancer; epidermal growth factor receptor (EGFR); lithium citrate; PIK3CA; receptor tyrosine kinase (RTK); METASTATIC COLORECTAL-CANCER; LUNG-CANCER; CETUXIMAB; MUTATIONS; KRAS; THERAPY;
D O I：
10.4161/cbt.11.3.14696
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：368 / 370
页数：3
相关论文
共 50 条
  • [21] Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma
    Hayes, Monica Prasad
    Douglas, Wayne
    Ellenson, Lora Hedrick
    GYNECOLOGIC ONCOLOGY, 2009, 113 (03) : 370 - 373
  • [22] Frequency and spectrum of PIK3CA somatic mutations in breast cancer
    Martinez-Saez, Olga
    Chic, Nuria
    Pascual, Tomas
    Adamo, Barbara
    Vidal, Maria
    Gonzalez-Farre, Blanca
    Sanfeliu, Esther
    Schettini, Francesco
    Conte, Benedetta
    Braso-Maristany, Fara
    Rodriguez, Adela
    Martinez, Debora
    Galvan, Patricia
    Rodriguez, Ana Belen
    Martinez, Antonio
    Munoz, Montserrat
    Prat, Aleix
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [23] Carcinogenesis of PIK3CA
    German, Sidra
    Aslam, Hafiz Muhammad
    Saleem, Shafaq
    Raees, Aisha
    Anum, Tooba
    Alvi, Arsalan Ahmad
    Haseeb, Abdul
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2013, 11
  • [24] PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
    Sartore-Bianchi, Andrea
    Martini, Miriam
    Molinari, Francesca
    Veronese, Silvio
    Nichelatti, Michele
    Artale, Salvatore
    Di Nicolantonio, Federica
    Saletti, Piercarlo
    De Dosso, Sara
    Mazzucchelli, Luca
    Frattini, Milo
    Siena, Salvatore
    Bardelli, Alberto
    CANCER RESEARCH, 2009, 69 (05) : 1851 - 1857
  • [25] PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis
    Aleskandarany, Mohammed A.
    Rakha, Emad A.
    Ahmed, Mohamed A. H.
    Powe, Desmond G.
    Paish, Emma C.
    Macmillan, R. Douglas
    Ellis, Ian O.
    Green, Andrew R.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (01) : 45 - 53
  • [26] Investigation of somatic PIK3CA gene mutations in breast cancer patients
    Pevzner, Alina M.
    Gaptulbarova, Ksenia A.
    Tsyganov, Matvey M.
    Ibragimova, Marina K.
    Vvedensky, Andrew V.
    Zhusina, Yulia G.
    Pyankov, Denis, V
    Korostylev, Sergey A.
    Litviakov, Nikolai, V
    JOURNAL OF BUON, 2021, 26 (03): : 747 - 752
  • [27] The Genomic Environment of BRAF Mutated and BRAF/PIK3CA Double Mutated Colorectal Cancers
    Voutsadakis, Ioannis A.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [28] Gene Mutations in Squamous Cell NSCLC: Insignificance of EGFR, KRAS and PIK3CA Mutations in Prediction of EGFR-TKI Treatment Efficacy
    Fiala, Ondrej
    Pesek, Milos
    Finek, Jindrich
    Benesova, Lucie
    Bortlicek, Zbynek
    Minarik, Marek
    ANTICANCER RESEARCH, 2013, 33 (04) : 1705 - 1711
  • [29] RNAi knockdown of PIK3CA preferentially inhibits invasion of mutant PIK3CA cells
    Zhou, Xin-Ke
    Tang, Sheng-Song
    Yi, Gao
    Hou, Min
    Chen, Jin-Hui
    Yang, Bo
    Liu, Ji-Fang
    He, Zhi-Min
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (32) : 3700 - 3708
  • [30] Activation of β-Catenin by Oncogenic PIK3CA and EGFR Promotes Resistance to Glucose Deprivation by Inducing a Strong Antioxidant Response
    Cardone, Luca
    Bardelli, Alberto
    Avvedimento, Vittorio Enrico
    PLOS ONE, 2012, 7 (05):
12345